InChI=1S/C20H30O5/c1-2-17(21)11-8-5-9-14-18(22)12-6-3-4-7-13-19(23)15-10-16-20(24)25/h3-9,11-13,17-19,21-23H,2,10,14-16H2,1H3,(H,24,25)/p-1/b4-3+,9-5-,11-8+,12-6+,13-7-/t17-,18+,19-/m1/s1 |
AOPOCGPBAIARAV-OTBJXLELSA-M |
C(\[C@H](CCCC([O-])=O)O)=C\C=C\C=C\[C@@H](C\C=C/C=C/[C@@H](CC)O)O |
|
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
|
|
anti-inflammatory agent
Any compound that has anti-inflammatory effects.
|
|
View more via ChEBI Ontology
(5S,6Z,8E,10E,12R,14Z,16E,18R)-5,12,18-trihydroxyicosa-6,8,10,14,16-pentaenoate
|
(5S,12R,18R)-trihydroxy-(6Z,8E,10E,14Z,16E)-eicosapentaenoate
|
SUBMITTER
|
(5S,12R,18R)-trihydroxy-(6Z,8E,10E,14Z,16E)-icosapentaenoate
|
ChEBI
|
resolvin E1
|
UniProt
|
RvE1(1−)
|
SUBMITTER
|
15753205
|
PubMed citation
|
SUBMITTER
|
16757471
|
PubMed citation
|
SUBMITTER
|
|